News/ News/ Sales and Marketing AZ closes $400 million Atacand sale to Germany’s Cheplapharm Phil Taylor AstraZeneca, Atacand, cardiovascular, Cheplapharm, Financial 0 Comment AstraZeneca has completed the sell-off of another mature product, hiving off its Atacand cardiovascular franchise to Cheplapharm as Share X AZ closes $400 million Atacand sale to Germany’s Cheplapharm https://pharmaphorum.com/news/az-closes-400-million-atacand-sale-to-germanys-cheplapharm/
Market Access/ News/ News Out with the old… AZ sells European rights to Atacand Piotr Wnuk AstraZeneca, Atacand, Cheplapharm 0 Comment AstraZeneca is selling off European commercial rights to its high blood pressure drug Atacand to German biotech Cheplapharm, Share X Out with the old… AZ sells European rights to Atacand https://pharmaphorum.com/news/out-with-the-old-az-sells-european-rights-to-atacand/
AstraZeneca, Atacand, cardiovascular, Cheplapharm, Financial
0 Comment
